key: cord-0280654-olhwycmz
authors: Lazari, L. C.; Zerbinati, R. M.; Rosa-Fernandes, L.; Santiago, V. F.; Rosa, K. F.; Angeli, C. B.; Schwab, G.; Palmieri, M.; Sarmento, D. J. S.; Marinho, C. R. F.; Almeida, J. D.; To, K. K.-W.; Giannecchini, S.; Wrenger, C.; Martinho, H.; Lindoso, J. A. L.; Durigon, E. L.; Braz-Silva, P. H.; Palmisano, G.
title: MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19
date: 2021-12-14
journal: nan
DOI: 10.1101/2021.12.10.21267596
sha: 3d600c53764d3506db74cf7d3c01e83ab41d4acd
doc_id: 280654
cord_uid: olhwycmz

The SARS-CoV-2 infections are still imposing a great public health challenge despite the recent developments in vaccines and therapy. Searching for diagnostic and prognostic methods that are fast, low-cost and accurate is essential for disease control and patient recovery. The MALDI-TOF mass spectrometry technique is rapid, low cost and accurate when compared to other MS methods, thus its use is already reported in the literature for various applications, including microorganism identification, diagnosis and prognosis of diseases. Here we developed a prognostic method for COVID-19 using the proteomic profile of saliva samples submitted to MALDI-TOF and machine learning algorithms to train models for COVID-19 severity assessment. We achieved an accuracy of 88.5%, specificity of 85% and sensitivity of 91.5% for classification between mild/moderate and severe conditions. Then, we tested the model performance in an independent dataset, we achieved an accuracy, sensitivity and specificity of 67.18, 52.17 and 75.60% respectively. Saliva is already reported to have high inter-sample variation; however, our results demonstrates that this approach has the potential to be a prognostic method for COVID-19. Additionally, the technology used is already available in several clinics, facilitating the implementation of the method. Further investigation using a bigger dataset is necessary to consolidate the technique.

Since its emergence in Wuhan in December 2019, the virus responsible for the Coronavirus Disease-2019 (COVID- 19) , SARS-CoV-2, has spread worldwide and become a world-threatening disease 1 with the vaccines which initial data indicating its use was efficient and safe [3] [4] [5] , the emergence of SARS-CoV-2 variants with the increased transmission is concerning 6 .

Thus, searching for new diagnosis and prognosis methods is still needed for increasing patient survival.

Regarding prognosis and diagnosis methods, simplicity, speed, low cost and accuracy are desirable qualities. Diagnosis methods for COVID-19 are present commonly in two forms, immunological assays or RT-qPCR; the former is a fast and cheap method, but can be very limited for early diagnosis since the immune response is still forming; the latter is considered the "gold standard" method and is the most used technique for COVID-19 diagnosis and disease tracking. However, the results are dependent of many factors, including proper sampling procedures and high-quality extraction kits 7, 8 . Variations on these methods have been implemented to achieve more accurate, affordable, easy to use and scalable diagnostic platforms 9, 10 . For being a relatively cheap and fast technique, MALDI-MS and machine learning algorithms have been implemented in many protocols, such as diagnosis and prognosis of several types of cancer [11] [12] [13] , fungi and bacterial identification 14, 15 , detection of resistant fungi and bacteria [16] [17] [18] , and COVID-19 diagnosis and prognosis [19] [20] [21] [22] [23] . However, these works used mainly plasma, serum or nasal swab samples, while saliva samples are still poorly explored. The process for collecting saliva is simple, fast, and painless and require minimum supervision 24 saliva also contains high amounts of SARS-CoV-2 during the early stages of viral infection 1 and a recent study demonstrated that the salivary glands serve as a viral reservoir 25 ; thus, this biofluid can be useful as source material for diagnosis and prognosis of COVID-19. Taken together, the rapid turnaround time (typically 10 min), high accuracy (>95%) for detection of extremely low concentration of biomolecules, low cost in supplies and technical processing indicates MALDI-MS as In this work, we propose a new method for COVID-19 diagnosis and prognosis using MALDI-TOF proteomic profile of salivary samples and machine learning.

Samples from patients in a mild/moderate or severe conditions were used to train several machine learning algorithms and build a model to classify the samples into mild/moderate or severe COVID-19 cases. Moreover, another model was built to classify between infected and control samples. Thus, two models were trained one for diagnosis and one for prognosis, using a rapid and widespread technique, MALDI-TOF, which is common in clinical laboratories. Further investigations and a larger cohort are necessary to consolidate this technique as an alternative test for COVID-19 diagnosis or prognosis.

All reagents used were from Sigma Aldrich unless otherwise stated.

This study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by Research Ethics Committee of the "Instituto de Infectologia Emílio Ribas", São Paulo, Brazil, protocol number CAAE 35589320.6.0000.0061. The invited volunteers were informed about the objectives, propositions and conditions of this project, in which those who agreed to participate in the research signed the free and informed consent term. Demographics, clinical data and samples were collected uniquely after the understanding of the study protocol and consent acknowledgement by the participants. A questionnaire on the health status of each participant was carried out. All participant information and samples were anonymized before use. Sample handling was carried out in a BSL2 laboratory.

COVID-19 infected-patients were classified in three groups according to the severity of the disease: 1) Mild form, characterized by the presence of flu-like symptoms, with the absence of dyspnoea and normal radiological examination. 2) Moderate, characterized by the presence of flu-like symptoms associated with pulmonary impairment < 50%, measured by computed tomography and O2 saturation >93% in room air. 3) Severe characterized by respiratory frequency greater than 30 breaths per minute, O2 saturation <93% in room air and pulmonary impairment >50% measured by computed tomography. During the period from January 13 to May 28, 2021 patients attending at the Instituto de Infectologia Emílio Ribas, Sao Paulo, Brazil, that tested molecularly positive for SARS-CoV-2 by nasopharyngeal swab were invited to enroll in the research study and provide saliva samples on the day of inclusion.

Individuals under 18 years old and pregnant women were excluded.

Healthcare workers group (controls). Asymptomatic healthcare workers potentially exposed to patients or SARS-CoV-2 positive samples were invited to enrol into the study. Saliva collection was performed on the day of individual inclusion and tested negative for SARS-CoV-2 by RT-PCR.

A standard protocol was used for nasopharyngeal swab. Routine diagnosis protocol was applied for SARS-CoV-2 detection by RT-qPCR.

Saliva samples were obtained from SARS-CoV-2 infected and healthy individuals by using a cotton pad device -Salivette™ (Sarstedt AG & CO. KG, Nümbrecht, Germany). The patients were asked to maintain the cotton in the mouth for 90 seconds; then, it was centrifuged at 1000 g for 5 minutes. After centrifugation, saliva Additionally, we tested if adding the same concentration of proteins for each sample in the MALDI plate would be better for group separation. For that, the protein quantification of all saliva samples was performed and a total of 0.2 μg of proteins All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

Samples were analyzed in a MALDI-TOF Autoflex speed smartbeam mass spectrometer (Bruker Daltonics, Bremen, Germany) using FlexControl software 

Data preprocessing and spectra evaluation were conducted using R packages.

First, fid files were converted to mzML using MSconvert available in ProteoWizard (version: 3.0.20220) 26 . The mzML files were loaded to R using MALDiquantForeign and processed using MALDIquant 27 . The spectra for each sample were transformed (square root), smoothed (Savitzky-Golay and halfWindowSize of 10) 28 and the base line corrected using the TopHat algorithm 29 . Then, the intensities were normalized using the total ion current and the peaks were selected with a signal-to-noise ratio of 2 and halfWindowSize of 10 22 . Peaks binning (tolerance of 0.003) and peak filtering (minimum frequency of 0.6) were performed for each group separately; then, a final binning (tolerance of 0.003) was performed with the groups merged. The resultant peaks were used to build an intensity matrix, which was further used for normality assessment (Shapiro-Wilk) and for a two-tailed Wilcoxon rank sum test corrected for multiple hypothesis testing using Benjamini-Hochberg. The peaks with a P-value < 0.05 were selected. The dataset was permuted 100 times and the global false discovery rate was calculated. For feature selection, the information gain method was used (FSelector All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 14, 2021. ; https://doi.org/10.1101/2021.12.10.21267596 doi: medRxiv preprint package), since it is faster than wrapper methods and is classifier independent 30 .

Features with weight higher than 0 were selected.

Six different algorithms were tested (SVM-P, GBM, SVM-R, NNET, NB, and RF) to classify samples in severe or mild/moderate and infected or control conditions. The training was carried through fourfold nested repeated ten times four-fold crossvalidation using the Caret package, the data was split randomly. A random search was performed for hyperparameter tunning in the inner loop. The MLeval package was used to plot the ROC and PR curves. The AUC of ROC curves, accuracy, sensitivity and specificity were reported. Since the infected and control groups are not balanced, the balanced accuracy was used.

For the classification between severe and mild/moderate, the model with the best performance was selected for a validation step using another set of samples (test set) prepared and acquired separately from the training samples. The same preprocessing was carried out for the test set samples separately from the training samples. However, train and test sets were binned together to generate comparable features. SVM-R demonstrated the best performance in the algorithm comparison step; thus, it was selected for model training in the validation step. The parameters were fixed at sigma = 0.003329177 and C = 0.8915975, since they were the parameters that achieved the best accuracy for SVM-R. The model training was conducted in two ways; (1) The training set was used directly for model training, then, the test set was applied to the model and the metrics were calculated; (2) an extra pre-processing step was performed in the training set prior to model training, we conducted a feature selection using the information gain algorithm (FSelector) to select the features with higher importance (weights higher than zero). After feature selection, the model was trained using only the selected features, then the test set was applied to evaluate the model performance. A schematic workflow is presented in Figure 1 .

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 14, 2021. ; 

In this study, we evaluated the potential of MALDI-TOF to identify prognostic biomarkers using saliva of COVID-19 patients. Initially, we tested a combination of analytical parameters to find the optimal conditions to obtain reliable and reproducible MS profiles (Figure 1) breathing difficulty (p=0.004) were statistically significant different between emergency room/department and ICU, being the latter the most prevalent in the patients treated in emergency rooms or hospitalized, and breathing difficulty most prevalent in ICU patients ( Table 1) . No statistical difference in sex and lower age for the controls was detected between COVID-19 patients and control subjects (Supplementary Table 1 ).

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The optimization step consisted in testing several approaches for spectra

acquisition. Initially, we tested the direct spotting method using several dilutions of the saliva. Three saliva samples were randomly selected from the cohort and analyzed in technical triplicates. We observed that direct spotting of samples diluted in a proportion were tested and their MS profile compared. Different spectra profiles were obtained, being HCCA with higher maximum intensity, and DHB with more peaks identified (Figure 2) . Although DHB had more peaks, we selected HCCA for the next analyses since it had lower variation in terms of number of peaks and maximum intensity. From these data it was possible to notice that analyses of technical replicates of the same saliva sample lead to less variation compared to different saliva samples (Figure 2B-C 

All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted December 14, 2021. ;

A small portion of the dataset (87 samples) was used to test whether loading the same amount of proteins in the MALDI plate would be better for group separation. We observed that loading 0.2 μg of proteins for each sample reduced the variation in the PCAs (Figure 2G and H) . Thus, for the machine learning analysis we decided to conduct sample spotting of the entire dataset using 0.2 μg of proteins. The variation obtained between MILD/MODERATE and SEVERE was higher compared to the variation obtained within the same condition.

This study was divided into two parts comparing the saliva samples of: 1) Table 5 ). Additionally, we performed an Information Gain filtering of the most relevant peaks and selected the 10 most ranked ones (Figure 3 F) and plotted the region of the most ranked peak (Figure 3 G) .

These data showed a pronounced difference between the two conditions. This prompted us to investigate the MS profile of saliva samples from COVID-19 patients harboring different clinical characteristics.

All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted December 14, 2021. ; https://doi.org/10.1101/2021.12.10.21267596 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 14, 2021. ; Wilcoxon rank sum test. The remaining peaks were used to plot the PCA ( Figure 4A) and train six machine learning models to classify between the conditions. The performance metrics for each model indicated that they differ, being the SVM-R the model with best mean accuracy (88.5%), mean sensitivity (91.5%) and mean specificity (85%) (Figure 4F and Supplementary Table 6 ). Also, specificity presented a high variation on every model tested, which was expected, since the saliva samples already presented a high variation in the PCA (Figure 4A) . This was not observed in our previous study using the same platform but plasma as biofluid 23 Additionally, we performed a feature selection by information gained to observe which were the most relevant peaks, the 10 most important peaks are reported in Figure 4B and the most rated peak is plotted in Figure 4C .

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 14, 2021. ; perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 14, 2021. ; https://doi.org/10.1101/2021.12.10.21267596 doi: medRxiv preprint them correctly. We trained the SVR-R algorithm using optimized parameters (sigma = 0.003329177 and C = 0.8915975) retrieved from model selection step. First, we applied the test set to the trained model without feature selection, this approach yielded in an accuracy of 67.18%, a sensitivity of 52.17% and specificity of 75.60%. Then, we tested whether training the model using features that were selected by the information gain method could generate a better result; however, the metrics obtained were slightly lower, with an accuracy of 65.62%, sensitivity of 50% and specificity of 70.83%. The values obtained are expected since we used an independent dataset to validate the model generated during the training step. Moreover, being the MALDI-TOF MS features extracted from saliva samples highly variable, it is expected to retrieve lower accuracy, sensitivity and specificity values.

The use of machine learning to build models for COVID-19 diagnosis has been already reported in the literature. Several approaches have been tested, including the use of X-ray imaging data 31 , emergency care admission exams 32 and routine blood tests 33 .

Also, mass spectrometry data have been used to train machine learning algorithms.

Among the biofluids used and the mass spectrometry techniques performed we can list the analysis of nasopharyngeal swabs in MALDI-TOF spectrometer to build models for COVID-19 diagnosis 22,34 , the analysis of proteomic profile of plasma samples by LC-MS/MS to build models for severity assessment and drug repurposing analysis 35 , the use of the metabolomic profile obtained from plasma samples submitted to direct injection on high resolution MS system to build models for COVID-19 diagnosis and risk assessment 21 , and the use of the proteomic profile of plasma samples submitted to MALDI-TOF to build models for COVID-19 risk assessment 23 . Many of the studies are performed using biofluids that are invasive, such as plasma and nasopharyngeal swabs, and uses data acquisition techniques that are relatively expensive and time demanding.

In order to slow down the disease spread, rapid and accurate identification of SARS-CoV-2 is necessary 36 ; thus, we describe here the use of a minimal invasive biofluid associated with MALDI-TOF, which is a relatively cheap and fast technique, for the diagnosis and prognosis of COVID-19 using machine learning algorithms. Our models attained a high performance, with the best model achieving an accuracy, sensitivity and specificity of 88.5%, 91.5% and 85% respectively for classifying between mild/moderate and severe cases of COVID-19; also, we achieved a balanced accuracy, sensitivity and specificity of 96.5%, 100% and 93.2% respectively for classifying between infected and control samples.

Although the models demonstrated a good performance in the training steps, the validation with independent data presented a lower performance than expected. It is known that the salivary proteome is a complex biofluid, with reports indicating an identification of 5500 proteins 37 . Also, there are several factors that contribute to interindividual variability of protein composition, such as taste stimulation, collection at different times of the day, age of infants, genetic polymorphism, and systemic pathologies 38 . Saliva collection was conducted in a standardized manner; however, it is extremely difficult to control the behavior of each individual prior to sample collection.

The direct spotting of the saliva samples might be another factor that contributed to the variability observed. Generally, direct spotting is more common in the literature, but other sample preparation methods might be applied prior spotting, such as protein digestion, glycoproteins enrichment, protein separation by electrophoretic gels, and peptide purification by C18 resins [38] [39] [40] [41] . Since our proposal was to develop the simplest yet accurate method for COVID-19 diagnosis, we did not evaluate the effect of more elaborate sample preparation methods; thus, further investigation is required in order to evaluate if the variability issue would be solved in the machine learning analysis.

We achieved a good accuracy for classifying between control and infected samples; however, it is important to note that our controls do not comprise samples obtained from patients that presented flu symptoms, meaning that it is still necessary to evaluate if the models trained are specific for COVID-19. Comparing infected patients with controls that presented similar symptoms is commonly done in the literature 19, 20, 22 ; however, since our study was aimed to prognosis, there were few control samples available in our cohort and all of them were from healthy patients. A study by Costa et al. (2021) demonstrated the potential of MALDI-TOF analysis of saliva samples and machine learning for COVID-19 diagnosis, they also reported high inter-individual variability and their models did not achieve sensitivity, specificity and accuracy values higher than 85% 42 ; our approach demonstrated a potential application for prognosis, and our models achieved similar performances, meaning that our results corroborates with what is expected for saliva samples. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 14, 2021. ;

May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients?

Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19

and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

SARS-CoV-2 variants and ending the COVID-19 pandemic

Laboratory diagnosis of SARS-CoV-2 -A review of current methods

Real-time RT-PCR in COVID-19 detection: issues affecting the results

Current and innovative methods for the diagnosis of COVID-19 infection (Review)

SARS-CoV-2 and the COVID-19 disease: A mini review on diagnostic methods

A novel algorithm for multi-class cancer diagnosis on MALDI-TOF mass spectra

Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning

Lipidomics as a diagnostic tool for prostate cancer

Performance of MALDI-TOF MS platforms for fungal identification

Adaption of the Aristotle Classifier for Accurately Identifying Highly Similar Bacteria Analyzed by MALDI-TOF MS

MS platform combined with machine learning to establish a model for rapid identification of methicillinresistant Staphylococcus aureus

Machine Learning Approach for Candida albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption/Ionization Timeof-Flight Mass Spectrometry

Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

Rapid Detection of COVID-19 Using MALDI-TOF-Based Serum Peptidome Profiling

Detection of SARS-CoV-2 Infection in Human Nasopharyngeal Samples by Combining MALDI-TOF MS and Artificial Intelligence

Covid-19 Automated Diagnosis and Risk Assessment through Metabolomics and Machine Learning

All rights reserved. No reuse allowed without permission. perpetuity

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 22

Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19

Saliva is a promising alternative specimen for the detection of SARS-CoV-2 in children and adults

Salivary glands are a target for SARS-CoV-2: a source for saliva contamination

A Cross-platform Toolkit for Mass Spectrometry and Proteomics

Maldiquant: A versatile R package for the analysis of mass spectrometry data

Smoothing and Differentiation of Data by Simplified Least Squares Procedures

Discovering splice junctions with RNA-Seq

FSelector: A Ruby gem for feature selection

New machine learning method for imagebased diagnosis of COVID-19

COVID-19 diagnosis prediction in emergency care patients: A machine learning approach. medRxiv (2020)

COVID-19 diagnosis by routine blood tests using machine learning

A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs

Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential

COVID-19 diagnostic approaches: different roads to the same destination

Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome

Inter-individual variability of protein patterns in saliva of healthy adults

Comparative proteomic analysis of whole saliva from chronic periodontitis patients

Influence of different sample preparation strategies on the proteomic identification of stress biomarkers in porcine saliva

Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry

Exploratory Study on Application of MALDI-TOF-MS to Detect SARS-CoV-2 Infection in Human Saliva

All rights reserved. No reuse allowed without permission. perpetuity

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted

This study demonstrates that MALDI-TOF MS and machine learning algorithms can be used to analyze saliva samples for prognosis purposes. This strategy is reproducible, easy to perform, fast, and low-cost. Since MALDI-TOF MS is already present in several clinical laboratories, this approach can be easily established in hospitals. However, it is important to note the limitations of this technique. We observed high inter-sample variation, which can reduce the performance of the models trained and reduce even more the performance during model generalization (validation with unseen data). This could be minimized by adding more samples to the cohort or by using more elaborate sample preparation methods. Therefore, a larger cohort should be analyzed to develop more robust models and inter-laboratory samples should be used to validate the findings. Moreover, improvements in the analytical part should be able to discriminate better between MILD and MODERATE groups.

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo